Hallett David
SEC CIK 2006495 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | CSO | 1.04M | — | — | 5 | 2026-02-06 | 2026-08-17 |
Most active insiders at RXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Borgeson Blake | Dir | — | $4.10M |
| 2 | Gibson Christopher | Dir | — | $3.84M |
| 3 | Khan Najat | Chief R, D Commercial Off, Dir | — | $806.7K |
| 4 | Taylor Ben R | CFO | — | $157.7K |
| 5 | Bumpus Namandje | Dir | — | $28.1K |
| 6 | Michor Franziska | Dir | — | — |
| 7 | Hallett David | CSO | — | — |
| 8 | Dar Zavain | Dir | — | — |
| 9 | Li Dean Y | Dir | — | — |
| 10 | Sun Elaine D | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 17:44 | 2026-08-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Hallett David | CSO | F - Tax | $3.16 | -26.7K | 1.04M | -2% | -$84.2K | |
| 2026-05-19 17:54 | 2026-05-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Hallett David | CSO | F - Tax | $3.04 | -26.7K | 1.07M | -2% | -$81.0K | |
| 2026-02-19 | 2026-02-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Hallett David | CSO | F - Tax | $3.49 | -11.9K | 1.10M | -1% | -$41.6K | |
| M | 2026-02-10 | 2026-02-06 | RXRX | RECURSION PHARMACEUTICALS, INC. | Hallett David | CSO | A - Grant | $0.00 | +526.3K | 1.10M | +92% | $0 |
| 2026-02-10 | 2026-02-06 | RXRX | RECURSION PHARMACEUTICALS, INC. | Hallett David | CSO | F - Tax | $3.98 | -11.4K | 1.11M | -1% | -$45.4K |
Purchase Sale Sale after option exercise All abbreviations